Interferon gamma release assays: principles and practice

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 4, 2010, Pages 245-252

  Lalvani, Ajit ^a   Pareek, Manish ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Interferon gamma release assays; Latent Tuberculosis; Review; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

BCG VACCINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; RISK FACTOR; SHORT SURVEY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; AUTOIMMUNE DISEASES; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORECASTING; HEALTH POLICY; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN TEST;

EID: 77951144872     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2009.05.012     Document Type: Short Survey

References (109)

1. WHO declares tuberculosis a global emergency. Soz Praventivmed 1993;38:251-2.
2. World Health Organisation. Global tuberculosis control-surveillance, planning, financing (2008), WHO, Geneva
3. Lalvani A. Diagnosing Tuberculosis Infection in the 21st Century: New Tools To Tackle an Old Enemy. Chest 131 (2007) 1898-1906
4. Barnes P.F. Diagnosing Latent Tuberculosis Infection. The 100-year Upgrade. Am J Respir Crit Care Med 163 (2001) 807-808
5. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country WHO Global Surveillance and Monitoring Project. JAMA 282 (1999) 677-686
6. Cain K.P., Benoit S.R., Winston C.A., and Mac Kenzie W.R. Tuberculosis Among Foreign-Born Persons in the United States. JAMA 300 (2008) 405-412
7. MacPherson D.W., and Gushulak B.D. Balancing prevention and screening among international migrants with tuberculosis: population mobility as the major epidemiological influence in low-incidence nations. Public Health 120 (2006) 712-723
8. Comstock G.W., Livesay V.T., and Woolpert S.F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99 (1974) 131-138
9. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174 (2006) 736-742
10. Wang L., Turner M.O., Elwood R.K., Schulzer M., and FitzGerald J.M. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57 (2002) 804-809
11. Cobelens F.G., Egwaga S.M., van Ginkel T., Muwinge H., Matee M.I., and Borgdorff M.W. Tuberculin Skin Testing in Patients with HIV Infection: Limited Benefit of Reduced Cutoff Values. Clin Infect Dis 43 (2006) 634-639
12. Lalvani A., Pathan A.A., McShane H., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163 (2001) 824-828
13. Mori T., Sakatani M., Yamagishi F., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170 (2004) 59-64
14. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M bovis. J Bacteriol 178 (1996) 1274-1282
15. Harboe M., Oettinger T., Wiker H.G., Rosenkrands I., and Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 64 (1996) 16-22
16. Lalvani A., and Millington K.A. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 20 (2007) 264-271
17. Lalvani A., and Millington K.A. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev 8 (2008) 147-152
18. Grzybowski S., and Enarson D. Results in pulmonary tuberculosis patients under various treatment program conditions. Bull Int Union Tuberc 53 (1978) 70-75
19. Kenyon T.A., Valway S.E., Ihle W.W., et al. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 334 (1996) 938-993
20. Stead W.W. Undetected tuberculosis in prison. Source of infection for community at large. JAMA 240 (1978) 2544-2547
21. Houk V.N., Baker J.H., Sorensen K., and Kent D.C. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 16 (1968) 26-35
22. Lalvani A., Pathan A.A., Durkan H., et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357 (2001) 2017-2021
23. Ewer K., Deeks J., Alvarez L., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
24. Richeldi L., Ewer K., Losi M., et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 170 (2004) 288-295
25. Shams H., Weis S.E., Klucar P., et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 172 (2005) 1161-1168
26. Zellweger J.P., Zellweger A., Ansermet S., de Senarclens B., and Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 9 (2005) 1242-1247
27. Brock I., Weldingh K., Lillebaek T., Follmann F., and Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170 (2004) 65-69
28. Connell T.G., Ritz N., Paxton G.A., Buttery J.P., Curtis N., and Ranganathan S.C. A Three-Way Comparison of Tuberculin Skin Testing, QuantiFERON-TB Gold and T-SPOT. TB in Children. PLoS ONE 3 (2008) e2624
29. Diel R., Loddenkemper R., Meywald-Walter K., Gottschalk R., and Nienhaus A. Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot. TB Test in Contact Investigations for Tuberculosis. Chest 135 (2009) 1018-1028
30. Dominguez J., Ruiz-Manzano J., De Souza-Galvao M., et al. Comparison of Two Commercially Available Gamma Interferon Blood Tests for Immunodiagnosis of Tuberculosis. Clin Vaccine Immunol 15 (2008) 168-171
31. Hill P.C., Brookes R.H., Adetifa I.M., et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 117 (2006) 1542-1548
32. Hill P.C., Brookes R.H., Fox A., et al. Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection. PLoS Medicine 4 (2007) e192
33. Nicol M.P., Davies M.-A., Wood K., et al. Comparison of T-SPOT. TB Assay and Tuberculin Skin Test for the Evaluation of Young Children at High Risk for Tuberculosis in a Community Setting. Pediatrics 123 (2009) 38-43
34. Soysal A., Millington K.A., Bakir M., et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366 (2005) 1443-1451
35. Detjen A., Keil T., Roll S., et al. Interferon-Gamma Release Assays Improve the Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Disease in Children in a Country with a Low Incidence of Tuberculosis. Clin Infect Dis 45 (2007) 322-328
36. Chun J.K., Kim C.K., Kim H.S., et al. The role of a whole blood interferon-gamma assay for the detection of latent tuberculosis infection in Bacille Calmette-Guerin vaccinated children. Diagn Microbiol Infect Dis 62 (2008) 389-394
37. Lighter J., Rigaud M., Eduardo R., Peng C.H., and Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 123 (2009) 30-37
38. Okada K., Mao T.E., Mori T., et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 136 (2008) 1179-1187
39. Nakaoka H., Lawson L., Squire S.B., et al. Risk for tuberculosis among children. Emerg Infect Dis 12 (2006) 1383-1388
40. Connell T.G., Curtis N., Ranganathan S.C., and Buttery J.P. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 61 (2006) 616-620
41. Tsiouris S.J., Austin J., Toro P., et al. Results of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis 10 (2006) 939-941
42. Dogra S., Narang P., Mendiratta D.K., et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. Journal of Infection 54 (2007) 267-276
43. Kang Y.A., Lee H.W., Yoon H.I., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293 (2005) 2756-2761
44. Dosanjh D.P., Hinks T.S., Innes J.A., et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 148 (2008) 325-336
45. Ferrara G., Losi M., D'Amico R., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
46. Jafari C., Ernst M., Kalsdorf B., et al. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med 174 (2006) 1048-1054
47. Janssens J.P., Roux-Lombard P., Perneger T., Metzger M., Vivien R., and Rochat T. Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis. Eur Respir J 30 (2007) 722-728
48. Kang Y.A., Lee H.W., Hwang S.S., et al. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132 (2007) 959-965
49. Lee J.Y., Choi H.J., Park I.N., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 28 (2006) 24-30
50. Ozekinci T., Ozbek E., and Celik Y. Comparison of tuberculin skin test and a specific T-cell-based test, T-Spot TB, for the diagnosis of latent tuberculosis infection. J Int Med Res 35 (2007) 696-703
51. Wang J.Y., Chou C.H., Lee L.N., et al. Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis 13 (2007) 553-558
52. Soysal A., Torun T., Efe S., Gencer H., Tahaoglu K., and Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M tuberculosis infection. Int J Tuberc Lung Dis 12 (2008) 50-56
53. Goletti D., Carrara S., Vincenti D., et al. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 12 (2006) 544-550
54. Meier T., Eulenbruch H.P., Wrighton-Smith P., Enders G., and Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24 (2005) 529-536
55. Ferrara G., Losi M., Meacci M., et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172 (2005) 631-635
56. Ravn P., Munk M.E., Andersen A.B., et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 12 (2005) 491-496
57. Dewan P.K., Grinsdale J., and Kawamura L.M. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44 (2007) 69-73
58. Kobashi Y., Obase Y., Fukuda M., Yoshida K., Miyashita N., and Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 43 (2006) 1540-1546
59. Mazurek G.H., Weis S.E., Moonan P.K., et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 45 (2007) 837-845
60. Bua A., Molicotti P., Delogu G., et al. QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol 30 (2007) 477-480
61. Kobashi Y., Mouri K., Yagi S., et al. Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med 47 (2008) 237-243
62. Kobashi Y., Mouri K., Yagi S., et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 133 (2008) 1196-1202
63. Nishimura T., Hasegawa N., Mori M., et al. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis 12 (2008) 269-274
64. Adetifa I.M., Lugos M.D., Hammond A., et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 7 (2007) 122
65. Pai M., Joshi R., Bandyopadhyay M., et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 35 (2007) 98-103
66. Palazzo R., Spensieri F., Massari M., et al. Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections. Clin Vaccine Immunol 15 (2008) 327-337
67. Tsiouris S.J., Coetzee D., Toro P.L., Austin J., Stein Z., and El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 44 (2006) 2844-2850
68. Lalvani A. Spotting latent infection: the path to better tuberculosis control. Thorax 58 (2003) 916-918
69. Chapman A.L., Munkanta M., Wilkinson K.A., et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16 (2002) 2285-2293
70. Liebeschuetz S., Bamber S., Ewer K., Deeks J., Pathan A.A., and Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364 (2004) 2196-2203
71. Mandalakas A.M., Hesseling A.C., Chegou N.N., et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 12 (2008) 417-423
72. Rangaka M.X., Diwakar L., Seldon R., et al. Clinical, Immunological, and Epidemiological Importance of Antituberculosis T Cell Responses in HIV-Infected Africans. Clinical Infectious Diseases 44 (2007) 1639-1646
73. Stephan C., Wolf T., Goetsch U., et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22 (2008) 2471-2479
74. Dheda K., Lalvani A., Miller R.F., et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19 (2005) 2038-2041
75. Clark S.A., Martin S.L., Pozniak A., et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol 150 (2007) 238-244
76. Raby E., Moyo M., Devendra A., et al. The Effects of HIV on the Sensitivity of a Whole Blood IFN-γ Release Assay in Zambian Adults with Active Tuberculosis. PLoS ONE 3 (2008) e2489
77. Balcells M.E., Perez C.M., Chanqueo L., et al. A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. Int J Infect Dis 12 (2008) 645-652
78. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L.R., and Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 7 (2006) 56
79. Luetkemeyer A.F., Charlebois E.D., Flores L.L., et al. Comparison of an Interferon-{gamma} Release Assay with Tuberculin Skin Testing in HIV-infected Individuals. Am J Respir Crit Care Med 175 (2007) 737-742
80. Jones S., de Gijsel D., Wallach F.R., Gurtman A.C., Shi Q., and Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis 11 (2007) 1190-1195
81. Matulis G., Juni P., Villiger P.M., and Gadola S.D. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67 (2008) 84-90
82. Ponce de Leon D., Acevedo-Vasquez E., Alvizuri S.G.C., Cucho M., et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35 (2008) 776-781
83. Vassilopoulos D., Stamoulis N., Hadziyannis E., and Archimandritis A.J. Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum. J Rheumatol 35 (2008) 1464
84. Cobanoglu N., Ozcelik U., Kalyoncu U., et al. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Int J Tuberc Lung Dis 11 (2007) 1177-1182
85. Takahashi H., Shigehara K., Yamamoto M., et al. Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration. Rheumatol Int 27 (2007) 1143-1148
86. Sellam J., Hamdi H., Roy C., et al. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis 66 (2007) 1610-1615
87. Bartalesi F., Vicidomini S., Goletti D., et al. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33 (2009) 586-593
88. Martin J, Walsh C, Gibbs A, et al. Comparison of interferon-{gamma}-release assays and conventional screening tests before tumour necrosis factor-{alpha} blockade in patients with inflammatory arthritis. Ann Rheum Dis 2009:ard.2008.101857.
89. Pai M., Zwerling A., and Menzies D. Systematic Review: T-Cell-Based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update. Ann Intern Med 149 (2008) 177-184
90. Arend S.M., Thijsen S.F., Leyten E.M., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 175 (2007) 618-627
91. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009:09031936.0075008.
92. Diel R., Loddenkemper R., Meywald-Walter K., Niemann S., and Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177 (2008) 1164-1170
93. Bakir M., Millington K.A., Soysal A., et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 149 (2008) 777-787
94. Hill P.C., Jackson-Sillah D.J., Fox A., et al. Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts. PLoS ONE 3 (2008) e1379
95. Doherty T.M., Demissie A., Olobo J., et al. Immune Responses to the Mycobacterium tuberculosis-Specific Antigen ESAT-6 Signal Subclinical Infection among Contacts of Tuberculosis Patients. J Clin Microbiol 40 (2002) 704-706
96. Higuchi K., Harada N., Mori T., and Sekiya Y. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school. Respirology 12 (2007) 88-92
97. Aichelburg M.C., Rieger A., Breitenecker F., et al. Detection and Prediction of Active Tuberculosis Disease by a Whole-Blood Interferon-gamma Release Assay in HIV-1-Infected Individuals. Clin Infect Dis (2009)
98. Verver S., Warren R.M., Munch Z., et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 363 (2004) 212-214
99. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control (2006), Royal College of Physicians, London
100. Public Health Agency of Canada. Interferon gamma release assays for latent tuberculosis infection: An Advisory Committee Statement CCDR 2007;33.
101. Mazurek G.H., Jereb J., Lobue P., et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54 (2005) 49-55
102. Diel R., Nienhaus A., and Loddenkemper R. Cost-effectiveness of Interferon-{gamma} Release Assay Screening for Latent Tuberculosis Infection Treatment in Germany. Chest 131 (2007) 1424-1434
103. Wrighton-Smith P., and Zellweger J.P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 28 (2006) 45-50
104. Millington K.A., Innes J.A., Hackforth S., et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 178 (2007) 5217-5226
105. Lalvani A., and Millington K.A. T cells and Tuberculosis: Beyond Interferon-Gamma. J Infect Dis 197 (2008) 941-943
106. Liu X.-Q., Dosanjh D., Varia H., et al. Evaluation of T-Cell Responses to Novel RD1- and RD2-Encoded Mycobacterium tuberculosis Gene Products for Specific Detection of Human Tuberculosis Infection. Infect Immun 72 (2004) 2574-2581
107. Harada N., Higuchi K., Yoshiyama T., et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M tuberculosis infection. J Infect 56 (2008) 348-353
108. Lalvani A., and Millington K.A. T-cell interferon-gamma release assays: can we do better?. Eur Respir J 32 (2008) 1428-1430
109. Ruhwald M., Bodmer T., Maier C., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32 (2008) 1607-1615